1. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61.
    2. Erectile dysfunction. NIH: National Institute of Diabetes and Digestive and Kidney Diseases. Accessed May 2015.
    3. DiMeo PJ. Psychosocial and relationship issues in men with erectile dysfunction. Urol Nurs. 2006 Dec;26(6):442-6.
    4. Phé V, Rouprêt M. Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies. Diabetes Metab. 2012 Feb;38(1):1-13.
    5. Shabsigh R, Lue TF. A Clinician’s Guide to ED Management. New York: Haymarket Media Inc.; 2006.
    6. Sexual and Urologic Problems of Diabetes. NIH: National Institute of Diabetes and Digestive and Kidney Diseases. Accessed May 2015.
    7. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009 May;6(5):1232-47.
    8. Hatzimouratidis K, Hatzichristou D. How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment. Curr Diab Rep. 2014;14(11):545.
    9. Walsh TJ, Hotaling JM, Smith A, et al. Men with diabetes may require more aggressive treatment for erectile dysfunction. Int J Impot Res. 2014 May-Jun;26(3):112-5.
    10. Montorsi F, Rigatti P, Carmingnani G, et al. AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institution study in 200 consecutive patients. Eur Urol. 2000 Jan;37(1):50-5.
    11. Gandaglia G, Briganti A, Jackson G, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014 May;65(5):968-78.
    12. Böhm M, Baumhäkel M, Teo K, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving Telmisartan, Ramipril, or both: The ongoing Telmisartan alone and in combination with Ramipril global endpoint trial/Telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. Circulation. 2010 Mar 30;121(12):1439-46.
    13. Jackson G, Rosen RC, Kloner RA, et al. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006 Jan;3(1):28–36.
    14. Haglind E, Carlsson S, Stranne J, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective controlled nonrandomized trial. Eur Urol. 2015 Aug;68(2):216-25.
    15. Wittmann D, Carolan M, Given B, et al. What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples’ sexual recovery after surgery for prostate cancer. J Sex Med. 2015 Feb;12(2):494-504.
    16. Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med. 2013 Jan;10(1):195-203.
    17. Viagra™ Prescribing information. Pfizer, Inc. Revised January 2010.
    18. Cialis™ Prescribing information. Lily USA, LLC. Revised October 2011.
    19. Levitra™ Prescribing information. Bayer HealthCare Pharmaceuticals. Revised November 2011.
    20. Osbon ErecAid™ Esteem™ Vacuum Therapy System User Guide. Timm Medical Technologies, Inc. 2011.
    21. Hellstrom WJ, Montague DK, Moncada I, et al. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010 Jan;7(1 Pt 2):501-23.
    22. Caverject™ Prescribing information. Pharmacia & Upjohn Company. Revised March 2014.
    23. Brant WO, Bella AJ, Lue TF. Treatment options for erectile dysfunction. Endocrinol Metab Clin North Am. 2007 Jun;36(2):465-79.
    24. MUSE™ Prescribing information. Meda Pharmaceuticals, Inc. Revised March 2011.
    25. AMS 700™ with MS Pump™ Penile Prosthesis Product Line Instructions for Use. American Medical Systems, Inc. 2016.
    26. GoodRx. Sample Savings with GoodRx. Accessed May 2015.
    27. Matthew AG, Goldman A, Trachtenberg J, et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol. 2005 Dec;174(6):2105-10.
    28. Scott FB, Bradley WE, Timm GW. Management of erectile impotence: use of implantable inflatable prosthesis. Urology. 1973 Jul:2(1):80-2.
    29. Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol. 2001 Sep;166(3):932-7.
    30. Bernal RM, Henry GD. Contemporary patient satisfaction rates for three-piece inflatable penile prostheses. Adv Urol. 2012;2012:707321.
    31. Data on file with Boston Scientific.
    32. FDA/PDP N970012-S065.
    33. Based on the Medicare 2015 deductible cap of $1260 for patients having an outpatient procedure. The estimated average out-of-pocket maximum for a patient with commercial insurance is $3,664 ($750-10,000). Medicare Advantage plans and private insurance plans vary in deductibles and coinsurance.
    34. Data on file with Boston Scientific.
    35. AMS 700™ Patient Manual. Information and Instructions for Patients Considering an Inflatable Penile Prosthesis. American Medical Systems, Inc. 2016.
    36. Catalona WJ. Conditions after a Radical Prostatectomy. Urological Research Foundation. Accessed May 2015.
    37. Enemchukwu EA, Kaufman MR, Whittam BM, et al. Comparative revision rates of inflatable penile prosthesis using woven Dacron® fabric cylinders. J Urol. 2013 Dec;190(6):2189-93.
    38. Carson CC III, Mulcahy JJ, Harsch MR. Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implant: up to 7.7 years of follow-up. J Urol. 2011 Feb;185(2):614-8.
    39. Spectra™ Concealable Penile Prosthesis Instructions for Use. American Medical Systems, Inc. 2017.
    40. Stendra™ Prescribing Information. Vivus, Inc. 2014.
    41. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007 Feb;120(2):151-7.
    42. Erectile dysfunction (ED). American Urological Association. Downloaded March 27, 2019.
    43. Catalona WJ. Sexual Potency after a Radical Prostatectomy. Urological Research Foundation. Accessed May 2015.
    44. Penile Implants-Erectile Dysfunction. Sex Health Matters: Accessed December 3, 2014.
    45. Erectile dysfunction (ED). American Urological Association. Accessed January 21, 2013.
    46. Data on file with Boston Scientific.
    47. Kloner R. Erectile dysfunction in the cardiac patient. Curr Urol Rep. 2003 Dec;4(6):466-71.
    48. Rajpurkar A, Dhabuwala CB. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol. 2003 Jul;170(1):159-63.
    49. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med. 1997 Jan 2;336(1):1-7.
    50. Costabile RA, Spevak M, Fishman IJ, et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol. 1998 Oct;160(4):1325-8.
    51. Sung HH, Ahn JS, Kim JJ, et al. The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors. Andrology. 2014 Jan;2(1):45-50.
    52. Ishii N, Watanabe H, Irisawa C, et al. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence. J Urol. 1989 Feb;141(2):323-5.
    53. Defade BP, Carson CC 3rd, Kennelly MJ. Postprostatectomy erectile dysfunction: the role of penile rehabilitation. Rev Urol. 2011;13(1): 6-13.
    54. WebMD. Erectile Dysfunction Health Center Slide Show: A Visual Guide to Erectile Dysfunction. Accessed March 23, 2016.
    55. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005 Jul-Aug;17(4):307-19.
    56. Miner MM, Kuritzky L. Erectile dysfunction: a sentinel marker for cardiovascular disease in primary care. Cleve Clin J Med. 2007 May;74 Suppl 3:S30-7. Review.
    57. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005 Dec 21;294(23):2996-3002.
    58. Montorsi P, Roumeguere T, Montosri F, et al. Is there a link between erectile dysfunction and cardiovascular disease? EAU Update Series 2. 2004 Jun:2;43-8.
    59. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug;87(8):766-78.
    60. American Diabetes Association. 2015 Fact Sheet. Accessed March 22, 2016.
    61. Jackson G, Boon N, Eardley I, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010 Jun;64(7):848-57.
    62. World Cancer Research Fund International. Accessed February 4, 2015.
    63. Catalona WJ. Conditions after a Radical Prostatectomy. Urological Research Foundation. Accessed May 2015.
    64. Frederick DA, Lever J, Gillespie BJ, et al. What keeps passion alive? Sexual satisfaction is associated with sexual communication, mood setting, sexual variety, oral sex, orgasm, and sex frequency in a national U.S. study. J Sex Res. 2017 Feb;54(2):186-201.
    65. Smith IA, McLeod N, Rashid P. Erectile dysfunction when tablets don’t work. Aust Fam Physician. 2010 May;39(5):301-5. Review.
    66. WebMD. Getting Intimate: Talking Together About ED. Accessed March 31, 2016.
    67. Wittmann D, Carolan M, Given B, et al. Exploring the role of the partner in couples’ sexual recovery after surgery for prostate cancer. Support Care Cancer. 2014 Sep;22(9):2509-15.
    68. Kerfoot WW, Carson CC. Pharmacologically induced erection among geriatric men. J Urol. 1991 Oct;146(4):1022-4.
    69. Mydlo JH, Volpe MA, MacChia RJ. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. BJU Int. 2000 Sep;86(4):469-73.
    70. Levine LA, Becher E, Bella A, et. al. Penile Prosthesis Surgery: Current recommendations From the International Consultation on Sexual Medicine. J Sex Med. 2016 Apr;13(4):489-518.
    71. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003;89(3):251-3.
    72. Oakley N, Moore KT. Vacuum devices in erectile dysfunction: indications and efficacy. Br J Urol. 1998 Nov;82(5):673-81.
    73. Saigal CS, Wessells H, Pace J, et al; Urologic DIAP. Predictors and Prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006 Jan;166(2):207–12.
    74. Tactra™ Malleable Penile Prosthesis Patient Manual. Information and instructions for patients considering a Tactra Malleable Penile Prosthesis. Boston Scientific. 2018.
    75. Tactra™ Malleable Penile Implant Directions for Use. Boston Scientific 2018.
    76. WebMD. Erectile Dysfunction: Penile Prosthesis. Accessed September 16, 2019.
    77. Penile Implant.[]=469&package[]=844 Accessed October 28, 2019.
    78. Data on file with Boston Scientific and based on market research by Northstar.
    79. US Census Files. Annual Estimates of the Resident Population for Selected Age Groups by Sex for the United States, States, Counties, and Puerto Rico Commonwealth and Municipios: 2018.
    80. Selvin E, Burnett AL, and Platz EA. Prevalence and Risk Factors for Erectile Dysfunction in the US. Am J Med. 2007: 120(2): 153.
    81. Mazur DJ, Gondokusumo JC, McBride JA, Pastuszak AW, Lipshultz LI. PD18-03 Doomed to Impotence: Analysis of Erectile Dysfunction (ED) and Inflatable Penile Prosthesis (IPP) Insurance Coverage From Verification Benefits Databases. The Journal of Urology. 2018 Apr 30;199(4): e390.

    82. Sellers T, Dineen M, Salem E, et al. Vacuum preparation, optimization of cylinder length and postoperative daily inflation reduces complaints of shortened penile length following implantation of inflatable penile prosthesis. Adv in Sex Med. 2013 Jan;3(91):14-8.
    83. Kamel I, Gadalla A, Ghanem H, et al. Comparing penile measurements in normal and erectile dysfunction subjects. J Sex Med. 2009 Aug;6(8):2305-10.

    84. AMS 700™ with MS Pump™ Penile Prosthesis Operating Room Manual. American Medical Systems. 2018.

    85. Salem EA, Wilson SK, Neeb A, et al. Mechanical reliability of AMS 700 CX improved by parylene coating. J Sex Med. 2009 Sep;6(9):2615-20.